[Aprostan application in the treatment of the diabetic foot, atherosclerotic arterial lesions in the stage of critical ischemia].
Mishalov
V H
VH
Seliuk
V M
VM
Cherviak
V A
VA
Litvinova
N Iu
NIu
D000208:Acute Disease; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications* / Q000503:physiopathology; D017719:Diabetic Foot / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D005528:Foot / Q000098:blood supply* / Q000503:physiopathology; D006801:Humans; D007511:Ischemia / Q000150:complications* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D014665:Vasodilator Agents; D000527:Alprostadil